Skip to main content
. Author manuscript; available in PMC: 2018 Oct 14.
Published in final edited form as: Cancer Cell. 2016 Jun 13;29(6):783–803. doi: 10.1016/j.ccell.2016.05.005

Figure 4. The onset of drug resistance is accompanied by YAP/TAZ activation.

Figure 4

(A-C) A) Drug sensitive cancer cells. The mechanism of YAP/TAZ activation in response to molecularly targeted therapies involves cell-autonomous events (B), such as cytoskeletal rearrangements leading to increased mechanosensitivity, as well as cell extrinsic events (C), such as remodeling of the extracellular microenvironment. Possibly, these two mechanisms cooperate to induce YAP/TAZ nuclear accumulation in cancer cells, leading to uncontrolled cell survival and proliferation in spite of drug administration.